|Oppenheimer||Mark Briedenbach Ph.D|
|The Benchmark Company, LLC||Bruce Jackson|
|Lake Street Capital Markets|
|Maxim Group||Jason McCarthy, Ph.D|
|Zacks||Anita Dushyanth, PhD|
|Aegis Capital Corp||Nathan Weinstein|
VolitionRx Ltd is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding VolitionRx Ltd's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of VolitionRx Ltd or its management. VolitionRx Ltd does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.